Cite
HARVARD Citation
Lorusso, D. et al. (n.d.). 366 Feasibility study of a network meta-analysis and unanchored population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in patients with newly diagnosed advanced ovarian cancer. International journal of gynecological cancer. pp. A71-A72. [Online].